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ABSTRACT 
 
Epigenetic reprogramming is a central component of the mammalian germline 
development. Genome-wide DNA demethylation observed in primordial germ cells 
(PGCs) is a prerequisite for erasure of epigenetic memory, preventing the transmission 
of epimutations to the next generation. Apart from DNA demethylation, germline 
reprogramming has been shown to entail reprogramming of histone marks and 
chromatin remodelling. Contrary to other animal models, there is limited information 
about the epigenetic dynamics during early germ cell development in humans. Here we 
provide further characterization of the epigenetic configuration of the early human 
gonadal PGCs. We show that early gonadal human PGCs are DNA hypomethylated and 
their chromatin is characterized by low H3K9me2 and high H3K27me3 marks. 
Similarly to the previous observation in the mouse, human gonadal PGCs undergo 
dynamic chromatin changes concomitant with the erasure of genomic imprints. 
Interestingly, and contrary to mouse early germ cells, expression of BLIMP1/PRDM1 
persists in all gestational stages in human gonadal PGC and is associated with nuclear 
LSD1. Our work provides important additional information regarding the chromatin 
changes associated with human PGCs development between 6 and 13 weeks of 
gestation in male and female gonads. 
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Introduction 
Primordial germ cells (PGCs) derived from epiblast of the pre-gastrulating embryos are 
the founder population of the future gametes. A unique characteristic of PGCs is the 
ability to acquire totipotency to give rise to the next generation. This ability is crucially 
underpinned by an existence of an extensive epigenetic reprogramming, that is a 
hallmark of PGC development in mammalian species [1,2]. Genome-wide DNA 
demethylation in mouse PGC results in the complete erasure of methylation marks in 
single-copy and imprinted genes, and a moderate reduction of methylation levels of 
retrotransposons and other repetitive elements [3,4]. This germline demethylation is 
critical for erasing epigenetic memory and preventing the transmissions of epimutations 
to the next generation [3,5]. Apart from dynamic changes in DNA methylation, early 
mouse germ cells are characterised by distinctive chromatin signature [1]. Reduction in 
the heterochromatin H3K9me2 mark observed in nascent mouse PGCs is followed by 
an increase in repressive H3K27me3 in migrating mouse germ cells between E7.5 and 
E8.5, at the time when these cells undergo G2 arrest and transcriptional quiescence [6]. 
Following their migration and the entry into the genital ridges, mouse PGCs undergo 
erasure of genomic imprints followed by major conformational changes in chromatin 
including loss of linker histone H1 and the replacement of nucleosomal histones [7,8]. 
Together, these dynamic events define a critical period for the epigenetic 
reprogramming in the mouse germ line [3,6,7]. 
 
Considerable progress has been made regarding our understanding of the molecular 
regulation of the mouse developing germ line in recent years.  In particular, the 
establishment of the germline fate has been attributed to the combination of three key 
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transcription factors: Blimp1/Prdm1, Prdm14 and Tfap2cAp2gamma [9,10] and the key 
transcriptional changes associated with the early mouse PGC development have been 
described. Interestingly, although it has been shown that cells recapitulating early 
mouse PGC development  (PGC like cells, PGClCs) can be derived in vitro from 
cultured pluripotent mouse ESCs, these cells resemble migratory mouse PGCs and 
require transplantation into the gonadal environment to undergo the epigenetic changes 
(including erasure of genomic imprints)  normally associated with the gonadal germline 
reprogramming [1,11]. These observations clearly advocate the need for better 
understanding of the gonadal germline reprogramming process on the molecular level. 
 
Most of our knowledge regarding mammalian germline development originates from 
studies in mice. Only limited knowledge is available regarding the sequence of events 
during PGC development in other species; studying these events in non-rodents is thus 
important to establish whether conserved mechanisms underlie PGC development in 
mammals. In this context, porcine model has been considered as a suitable model to 
study mammalian development [12,13], due to the developmental and physiological 
similarities with most other mammals, including humans. Recent studies of porcine 
PGCs demonstrated that, similarly to previous observation in the mouse,  
reprogramming of H3K9me2 and H3K27me3 histone marks precedes also germline 
DNA demethylation in pig, suggesting that hallmarks of germline epigenetic 
reprogramming might be conserved [14,15]. Nonetheless, limited information is 
available regarding these epigenetic events in human. 
  
The presented study focuses on the investigation of the gonadal epigenetic 
reprogramming in the human germ line. Our results document that early human gonadal 
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PGCs are DNA hypomethylated and share the distinct chromatin configuration 
previously observed in PGCs in the mouse and pig. Using bisulphite sequencing of the 
isolated human gonadal PGCs we furthermore show, that the imprinted H19 DMR 
undergoes methylation erasure around week 11 of gestation. This is accompanied by 
loss of H3K27me3 and dynamic gain in transcriptionally permissive histone 
modifications. Our results thus draw parallels between the chromatin changes observed 
in human gonadal germ cells and the previously described observations in the mouse 
and pig PGCs.  Interestingly, although in the mouse Blimp1/Prdm1 expression is lost in 
PGCs soon following their entry into the genital ridge, human PGCs retain 
BLIMP1/PRDM1 expression in all gestational stages analysed (up to 12 weeks of 
gestation). Expression of this germline determinant is also not associated with nuclear 
PRMT5 as previously observed in the mouse [16], but is concomitant with the nuclear 
LSD1, a histone demethylase previously shown to associate with BLIMP1/PRDM1 in 
human plasma cells [17].  
Collectively, our work provides new information about human PGCs reprogramming in 
vivo aiding to our efforts towards understanding of the cellular and epigenetic 
mechanisms leading to and governing human totipotency.  
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Materials and Methods 
 
Human fetal sample collection 
Human fetal samples from 6 to 13 weeks postconception (wpc) were used. Oral and 
written information was given and informed consent was obtained from all women, 
according to and approved by The Spanish and Catalan Committee on Biomedical 
Research Ethics (Nº:1811521). Calculation of gestational age was based on the 
information about the last menstrual period, and measurements of crown rump and foot 
lengths. The sex of all samples was confirmed by performing genomic PCR for human 
gender determination according to US patent (US007432362B2) (Suppl Fig 1). 
 
Immunofluorescence microscopy 
The specimens were fixed in 4% paraformaldehyde, dehydrated with graded alcohols, 
cleared in xylene and embedded in paraffin wax. Serial sections (5µm) were de-
paraffinized, rehydrated and antigen retrieval (pH:9) was performed. The 
immunofluorescence staining was performed as previously described [18] The 
following antibodies and their dilutions were used: OCT-3/4 (sc-5279 and sc-8628, 
SantaCruz, 1:25), NANOG (AF1997, R&D systems, 1:25), SSEA-1 (MC-480, 
Developmental Studies Hybridome Bank at University of Iowa, 1:1), cKIT/CD117 
(A4502, Dako, 1:100), VASA (AF2030, R&D systems, 1:20), H3K4me1 (ab8895, 
Abcam, 1:50), H3K9ac (ab10812, Abcam, 1:50), H3K27me3 (07-449, Millipore, 1:50), 
H3K4me3 (07-473, Millipore, 1:50), H3K9me2 (07-441, Millipore, 1:50), H3K9me3 
(07-442, Millipore, 1:50), LSD-1 (ab17721, Abcam, 1:50), DHX38 (10098-2-AP, 
ProteinTech Group, 1:50), PRMT5 (sc-22132, SantaCruz, 1:25), BLIMP1 (9115S, Cell 
Signalling, 1:100) . The Alexa Fluor Series from Invitrogen were used as secondary 
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antibodies (all 1:200). Images were taken using a Leica SP5 confocal microscope. 
Quantitative analyses were performed by counting cKIT/OCT4 and VASA/OCT4. Data 
are expressed as mean ± SD (Suppl Fig 2). 
 
Quantification of staining intensity by confocal microscopy 
The quantification of staining intensity was performed using LAS AF Leica Software. 
Fluorescence was detected using same confocal settings. Mean fluorescence 
intensity/area values were measured for 30 nuclei germ cells and surrounding somatic 
cells. To normalize between different samples, the intensity of each histone mark 
staining was calculated as the mean pixel intensity in every PGC divided by the mean 
pixel intensity in surrounding somatic cells [7] (Suppl Fig 7). The error bars represents 
standard deviations. Statistics of immunofluorescence staining data according to T-tests  
significance [p <0.05 (*), p<0.01 (**) and p<0.001 (***)] (Fig 1, Fig 2, Fig 3, Fig 4, Fig 
6, Suppl Fig 3 and Suppl Fig 4). 
 
5meC staining 
Sections were dewaxed, rehydrated and antigen retrieval (pH:6) were performed. In 
order to block non-specific binding, alkaline phosphatase and endogenous peroxidase 
activity, sections were first blocked with 3% donkey serum, secondly were incubated 
with levamisole and finally treated with 2% H2O2. All sections were incubated with 
VASA (AF2030, R&D systems, 1:25) and 5meC (16233D3, Calbiochem, 1:50) 
antibodies. For detecting VASA antibody, sections were incubated with a secondary 
antibody alkaline phosphatase conjugated (705-055-147, Jackson Lab., 1:100). Finally 
sections were revealed by using EnVisionTM System, BCIP/NBT (Dako) and DAB. 
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Isolation of human PGCs 
Human fetal gonads were dissociated in 0.25% trypsin-EDTA (Gibco) at 37º C for 20 
min and collected by centrifugation at 2000 rpm in a microcentrifuge. Dissasociated 
cells were resuspended in a buffer containing 1% FBS (Gibco). cKit+/CD117+ cells 
were selected by using an immunomagnetic separation system (MiniMACS, 130-091-
332, Miltenyi Biotec).  Purification efficiency (higher than 90%) was verified by 
alkaline phosphatase staining (SK-5100, Vector Laboratories) (Suppl Fig 1).  
 
 
Promoter methylation analysis 
The isolated hPGCs and their gonadal somatic cells were embedded in agarose, lysed 
and the chromosomal DNA subjected to the bisulphite treatment [19]. The promoter 
sequences for H19 were amplified by a nested PCR with two subsequent reactions using 
primers and conditions previously described [20,21]. The resulting amplified products 
were cloned into pGEM T Easy plasmids, amplified in TOP10 chemically competent 
cells, purified and sequenced. Plasmid purification and sequencing were performed for 
at least 12-20 positive clones. To analyse the data, mutagenesis rates of > 95%, 
excluding putative methylation sites, were considered acceptable to proceed. Sequences 
were aligned to the reference sequence by Quantification tool for methylation analysis 
(QUMA). Percentage of methylation was calculated according to the number of 
conserved CpG islands related to the total CpG islands analysed. 
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Results 
The dynamics of cKIT, VASA, OCT4 and NANOG expression in human fetal gonads. 
Following their migration, human PGCs have been shown to colonize the fetal gonads 
between week 6 and 8 of gestation [22].To follow epigenetic changes occurring during 
human early gonadal PGC development, we have collected and analysed 90 samples of 
human fetal gonads between week 6 and 13 of gestation. We first carried out assessment 
of the expression of cKIT, VASA, OCT4 and NANOG in human fetal gonads (male and 
female) between 6 to 12 weeks of gestation by immunofluorescence. We observed that 
cKIT, VASA, OCT4 and NANOG were present in PGCs of all stages studied in both 
sexes. Expression of these markers was restricted to germ line, as expected.  Although 
all human PGCs were expressing cKIT across all analysed stages (see also [23]) early 
gonadal PGCs showed heterogeneity in VASA staining (gestation week 6-9) (see 
asterisks in Fig 1, Fig 5, Fig 6 and Suppl. Fig 5). Additionally, starting from gestation 
week 11 we observed presence of PGCs that were VASA+/cKIT+ but OCT4-/NANOG- 
(see arrows in Suppl Fig 2 and arrowheads in Fig 1). We note that this timing coincides 
with the reported initiation of meiosis in human female PGCs [18] (Suppl Fig 2). In this 
context mouse gonadal PGCs have been shown to downregulate Oct4 expression upon 
entry into meiosis [24]. 
 
Unique germline epigenetic signature is conserved across species   
Chromatin features of the mouse early germ cells have been extensively studied [5,7].  
In the mouse, early PGCs are characterized by a genome-wide loss of H3K9me2, a 
facultative heterochromatin mark, followed by global increase in the polycomb 
H3K27me3 histone modification [5,7].  Interestingly, the same chromatin configuration 
is recapitulated in in vitro mouse derived PGC like cells (PGCLCs) [11,25]. In order to 
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understand whether this specific germline chromatin configuration is conserved also in 
human we stained human fetal gonads cells with specific antibodies recognizing these 
chromatin marks. Consistent with findings in the mouse, both male and female human 
PGCs stained weakly or below the level of detection for H3K9me2 in comparison with 
somatic cells across all gestational stages analysed (Fig. 1; Suppl Fig 7). In addition, 
early gonadal PGCs (gestation week 6-8 in the male and 6-7 in the female) were 
characterized by high level of H3K27me3 in comparison to the surrounding somatic 
cells of the fetal gonad (Fig. 2; Suppl Fig 7). This confirms that the chromatin germline 
signature observed in the mouse might be conserved across species and thus represents 
a unique germline attribute. 
Although low H3K9me2 persists in the pre-meiotic mouse PGCs, H3K27me3 observed 
in the migratory and early postmigratory PGCs disappears around the time of imprint 
erasure (E11.5 in the mouse, [7]). Strikingly, and in agreement with the previous 
observations [23], H3K27me3 diminishes also in human PGCs of both sexes after 9 
weeks of gestation in (Fig. 2; Suppl Fig 7). 
 
Chromatin modifications, permissive and repressive marks 
To provide further characterization of the global chromatin dynamics during human 
PGC development, PGCs and somatic cells were stained with specific antibodies 
against the transcriptionally permissive marks: H3K4me1, H3K4me3 and H3K9ac. 
Male and female germ cells stained strongly for H3K4me1 and H3K4me3 in 
comparison with the surrounding somatic cells in most of gestational stages analyzed 
(Suppl Fig. 3; Suppl Fig 7 and Fig. 3). Although H3K9ac was also generally higher in 
PGCs than in the surrounding somatic cells, we observed a clear peak of signal from 10 
to 13 weeks of gestation in both sexes (Fig. 4; Suppl Fig 7).  
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Contrary to general enrichment of transcriptionally permissive chromatin marks, we 
observed lower H3K9me3 staining in male germ cells in comparison with the 
surrounding somatic cells, (Suppl Fig. 4 and Suppl Fig 7). This was not apparent in the 
female samples. 
 
Methylation status of human gonadal PGCs 
Dominant feature of the germline chromatin is the global erasure of DNA methylation 
(5meC) [1,6,26]. In the mouse, although decrease in global 5mC levels is detectable 
following the establishment of the low H3K9me2/ high H3K27me3 global chromatin 
signature in migrating PGCs [5], the complete removal of genome-wide DNA 
methylation including the erasure of genomic imprints proceeds only once the mouse 
PGCs colonized the genital ridges of the midgestation mouse embryo at E11.5 [4,7].   
In order to understand the general methylation status of human PGCs we carried out 5-
methyl cytosine (5meC) staining in combination with a germ cell specific marker, 
VASA. Our results indicate that the 5meC levels detected in human gonadal PGCs were 
lower than those found in the surrounding gonadal somatic cells. We also note that this 
became particularly apparent from gestation week 10 (Suppl Fig 1). 
We next evaluated the DNA methylation status of the promoter of the maternally 
expressed, paternally imprinted gene H19. First, human PGCs were isolated by MACS 
at different gestational stages using magnetic beads coupled to c-KIT antibody. The 
purity of the isolated PGCs was confirmed (90-95%) by Alkaline Phosphatase staining 
(Suppl Fig 1). Bisulphite sequencing analysis revealed that in the PGCs of both genders, 
H19 DMR shows an apparent loss of methylation starting from gestation week 9. In 
male PGCs we detected a decrease from 80% to 29%; in female PGCs we detected a 
decrease from 60% to 20% (Suppl Fig 1).  The loss of methylation at the H19 DMR 
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corresponds with the timing of the pronounced global DNA hypomethylation observed 
in the human gonadal PGCs by 5mC at gestation week 10 as discussed above (Suppl Fig 
1). Concomitantly all these changes coincide with the timing of the observed chromatin 
changes (loss of H3K27me3 – Fig 2 and upregulation of H3K9ac – Fig 4). 
 
Blimp1-Prmt5 complex 
Data from murine model indicates the important role of BLIMP/PRMT5 complex and 
his target DHX38 during the specification of the mouse PGCs within the epigenetic 
program. In order to ascertain whether the expression of BLIMP1/PRMT5 complex 
follows a similar pattern to the one described in mouse we evaluated the presence of this 
complex during human PGCs development. Although we confirmed germline specific 
expression of BLIMP and high expression levels of PRMT5 in human PGCs, we 
consistently found that the expression of BLIMP1 was restricted to the nucleus whereas 
PRMT5 expression was mainly localized in the cytoplasm of PGCs in both sexes across 
all gestational stages examined (Fig 5 and Suppl Fig 5).  
Dhx38 helicase has been previously shown to be one of the targets repressed by the 
Blimp1/Prmt5 complex in the mouse PGCs [16].  In agreement with the apparent lack 
of the BLIMP/PRMT5 complex formation in the human gonadal PGCs, DHX38 was 
found in both nucleus and cytoplasm of all analysed human PGCs independently of 
gestational stage and sex (Suppl Fig.6). 
 
It has been previously shown that during plasma cell differentiation BLIMP1 directly 
interacts with the histone lysine demethylase, LSD1 [17]. Considering the lack of 
evidence for the BLIMP/PRMT5 complex formation in the human gonadal PGCs it is of 
interest that we detected high amount of LSD1 protein in male and female PGCs in 
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comparison with the somatic cells in all analysed gestational stages   (Fig. 6; Suppl. Fig 
7). 
 
Discussion 
The presented study provides characterization of epigenetic changes in early human 
gonadal PGCs from 6 to 13 weeks of gestation. We evaluated the epigenetic status of 
human PGCs by assessing changes in global chromatin marks, the methylation status of 
H19 imprinted gene and changes associated to methylation status genome-wide. 
 
We first characterized the expression of markers associated with stem cells and 
pluripotency during the early gonadal stages of human PGC development. In agreement 
with previous studies [14,23,24,27,28,29] we show that gonadal PGCs are characterized 
by cKIT expression. Although it has been previously reported that human gonadal 
PGCs are expressing SSEA-1 [30, 31], the expression of this marker is not restricted to 
PGCs in human fetal gonads (Suppl Fig 2C). In agreement with a recent publication 
[28], we observed that majority of PGCs were VASA positive at 6 weeks of gestation, 
however all human PGCs were VASA positive by 9 weeks of gestation. This is in 
agreement with the mouse model, where Vasa (mvh) expression becomes prominent 
only once mouse PGCs colonize the genital ridges [32].  All early human gonadal PGCs 
express OCT4 and NANOG, but the proportion of OCT4 and NANOG positive germ 
cells declines from gestation week 9 onwards, with the fraction of  cKIT +/OCT4- 
PGCs increasing up to 25% in late stages (w12-w13). Our data are thus in agreement 
with the recently published observations [28]. The absence of expression of OCT4 in 
female PGC samples coincides with the reported entry of human PGCs into meiosis 
[22,31] as also previously observed in the mouse [24].  
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In the mouse, pre-migratory PGCs initiate a process of reprogramming that erases 
epigenetic marks. One of the key epigenetic changes in pre-migratory and early 
migratory mouse PGCs is a loss of H3K9me2 that is closely followed by an 
accumulation of H3K27me3 signal [5,7,25].  Interestingly, our stainings of early human 
gonadal PGCs confirm the presence of analogous chromatin changes also in the human 
early developing germ line (Fig 1 and 2) [27,28,29].  As similar changes in global 
chromatin configuration has been also reported in porcine PGCs, our findings clearly 
document that unique chromatin features of early germ line are conserved, at least 
within mammalian clade.  
 
Following their entry into the genital ridges, mouse PGCs undergo erasure of genomic 
imprints and dynamic changes in chromatin modifications [7]. In analogy to the mouse 
model and in agreement with recent publications [23,27,28,29], our results show that 
human gonadal PGCs lose H3K27me3 following week 9 of gestation.  Again, similar 
observation has been previously made using porcine model further strengthening the 
notion of the existence of the conserved mechanism underlying germline epigenetic 
reprogramming [15].  
Interestingly, also in the human gonadal PGCs, the timing of the H3K27me3 loss 
overlaps with the observed reduction of DNA methylation at imprinted H19 DMR and 
also with a clear global hypomethylated state as observed by global 5mC staining 
(Suppl Fig 1).  This finding yet again parallels similar observations in the mouse, pig 
and human models [7,14,15,27,28,29].   We also notice, that the presence of the early 
germline chromatin signature (low H3K9me2, H3K27me3) prior to the erasure of 
genomic imprints defines a distinct developmental window with high propensity of 
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PGCs to give rise to pluripotent embryonic germ (EG) cells in both mouse and human 
[30,31,32,33,34,35,36]. 
 
Finally, Blimp1, a transcriptional repressor, has been described as one of the key 
determinants of the mouse germ line [10,16]. In the mouse migratory and early post-
migratory PGCs, Blimp1 has been reported to form a repressive regulatory complex 
with Prmt5, a type II arginine specific histone methyltransferase [16]. Although a 
previous report suggested a possible existence of a similar regulatory complex also 
during human PGC development [27,29,37], our data clearly show that BLIMP1 
expression is restricted to the nucleus of PGCs in human fetal gonads (Fig 5), while 
PRMT5 shows cytoplasmic localization in human germ cells across all gonadal stages 
analysed (Suppl Fig 5).  In addition, DHX38, a target of repressive Blimp1/Prmt5 
complex in the mouse PGCs [16], was found to be expressed in all stages of human 
PGCs analysed in our study (Suppl Fig 6).   
 
Although our observations argue against the presence of the nuclear BLIMP1/PRMT5 
complex in early gonadal human PGCs, we note that nuclear BLIMP1 coincides in 
human PGCs with high levels of Lysine-specific demethylase-1 (LSD1) (Fig. 6). In this 
context, BLIMP1 has been previously shown to interact with LSD1 during human 
plasma cell differentiation [17]. Additionally, LSD1 has been implicated in gene 
silencing in Drosophila PGCs and also during germline reprogramming in C.elegans 
[38,39,40]. Further biochemical and functional studies will thus be required to confirm 
the functional relevance of this intriguing observation.  
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In summary our study provides further characterization of the epigenetic changes 
observed in early human gonadal PGCs (Fig 7) and thus complements the recently 
published genome-wide transcriptional and methylation studies [27,28,29]. Although 
the relative timing might differ due to species specific developmental progression, our 
data show that key epigenetic changes observed in the germ line are conserved between 
mouse, pig and human.  Our work further demonstrates that gonadal epigenetic 
reprogramming starts in human PGCs around 9 weeks of gestation (Fig 7), which is in 
agreement with the recently published observations [27,28,29].   Last, but not least, our 
observations regarding BLIMP/PRMT5 complex highlight potential differences 
between germline regulatory complexes in mouse and human and suggest a potential 
role for LSD1 as a new epigenetic regulator during gonadal reprogramming in humans. 
 
Conclusion 
In summary our work provides new information about human PGCs reprogramming in 
vivo aiding to our efforts towards understanding of the cellular and epigenetic 
mechanisms leading to and governing human totipotency.  
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Figure legends 
Figure 1. Chromatin changes of H3K9me2  in human fetal PGCs.  
A Immunofluorescence of primordial germ cells and somatic cells for detecting 
H3K9me2 (green), VASA (red), OCT4 (yellow) and DAPI (blue) proteins. Fetal ovaries 
and testis were stained. Scale bar 10 µm. (*: Heterogeneity in VASA staining; 
arrowheads: VASA+/OCT4- cells). 
B Quantification of H3K9me2 signal in human germ and somatic cells. The error bars 
represent standard deviation. (p<0.05 in some stages of fetal testis). 
Figure 2. Chromatin changes of H3K27me3  in human fetal PGCs.  
A Immunofluorescence of primordial germ cells and somatic cells for detecting 
H3K27me3 (green), VASA (red), OCT4 (yellow) and DAPI (blue) proteins. Fetal 
ovaries and testis were stained. Scale bar 10 µm.  
B Quantification of H3K27me3 signal in human germ and somatic cells. The error bars 
represent standard deviation. (p<0.05 in a stage of fetal ovaries) 
Figure 3. Chromatin changes of H3K4me3 in human fetal PGCs.  
A Immunofluorescence of primordial germ cells and somatic cells for detecting 
H3K4me3 (green), VASA (red), OCT4 (yellow) and DAPI (blue) proteins. Fetal ovaries 
and testis were stained. Scale bar 10 µm.  
B Quantification of H3K4me3 signal in human germ and somatic cells. The error bars 
represent standard deviation. (p<0.05 in a stage of fetal testis;  p<0.01 in a stage of fetal 
ovaries). 
 
Figure 4. Chromatin changes of H3K9ac in human fetal PGCs.  
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A Immunofluorescence of primordial germ cells and somatic cells for detecting H3K9ac 
(green), VASA (red), OCT4 (yellow) and DAPI (blue) proteins. Fetal ovaries and testis 
were stained. Scale bar 10 µm.  
B Quantification of H3K9ac signal in human germ and somatic cells. The error bars 
represent standard deviation. (p<0.05; p<0.01 in some stages of fetal testis and ovaries).   
Figure 5. The expression of Blimp1 in human fetal gonads. Immunofluorescence of 
primordial germ cells and somatic cells for detecting BLIMP1 (green), VASA (red), 
OCT4 (yellow) and DAPI (blue) proteins. Scale bar 10 µm. (*: Heterogeneity in VASA 
staining). 
A Fetal testis from 7 to 12 weeks of gestation 
B Fetal ovaries from 7 to 12 weeks of gestation.  
Figure 6. Chromatin changes of LSD1 in human fetal PGCs.  
A Immunofluorescence of primordial germ cells and somatic cells for detecting LSD1 
(green), VASA (red), OCT4 (yellow) and DAPI (blue) proteins. Fetal ovaries and testis 
were stained. Scale bar 10 µm. (*: Heterogeneity in VASA staining). 
B Quantification of LSD1 signal in human germ and somatic cells. The error bars 
represent standard deviation. (p<0.05 in some stages of fetal testis and ovaries; p<0.01 
in a stage of fetal ovaries). 
Figure 7. Summarized time course of human gonadal epigenetic reprogramming 
A Cellular dynamics and gonadal epigenetic reprogramming in human germ cells 
B Mouse, Pig and Human epigenetic reprogramming time window in germ line 
Supplementary Figure 1. Changes of global DNA methylation and methylation 
status of H19 gene in human PGCs. 
A Primordial germ cells and somatic cells were double stained with VASA antibody 
(blue) in the cytoplasm and 5meC antibody (brown) in the nucleus. 
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Immunohistochemistry by using fetal ovaries and testis from 7 to 12 weeks of gestation. 
Cells in blue are PGCs and cells in brown are somatic cells. Scale bar 10 µm. 
B Schematic of expected methylation status of 18 CpG islands in region 2000-2200 of 
the H19 differentially methylated region (DMR). Each lane of circles represents one 
individual clone. Open circles represent unmethylated CpGs, and closed circles 
represent methylated CpGs. 
C CpGs in the H19 promoter DMR were analysed by bisulphite sequencing in male 
PGCs from 7 to 11 weeks of gestation 
D CpGs in the H19 promoter DMR were analysed by bisulphite sequencing in female 
PGCs from 7 to 10 weeks of gestation   
E Control of somatic cell from gonads 
F Sexing PCR. To determine the sex of the fetal gonads we performed a genomic PCR. 
M: male; F: female; CM: control male and CM: control female.  
G Alkaline phosphatase staining. To determine the purity of the cKIT+ 
immunomagnetic separation technique (MiniMACs) we performed the tissue non-
specific alkaline phosphatase staining, (a) cKIT positive fraction and (b) cKIT negative 
fraction. 
Supplementary Figure 2. Characterization of the human fetal gonads.  
A Immunofluorescence of primordial germ cells and somatic cells for detecting OCT4 
(green), cKIT (red), NANOG (yellow) and DAPI (blue) proteins. Fetal ovaries from 6 
to 12 weeks of gestation and fetal testis from 7 to 12 weeks of gestation were stained. 
Scale bar 25 µm. (Arrows: cKIT+/OCT4-/NANOG- cells). 
B The dynamics of cKIT, OCT4 and VASA expression in the fetal gonad. 
Quantification cKIT+, OCT4+, VASA+, cKIT+/OCT4+ and VASA+/OCT4+ in fetal 
ovaries and testis 
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C Immunofluorescence of primordial germ cells and somatic cells for detecting SSEA1 
(red), NANOG (green) and DAPI (blue) proteins. Fetal testis from 14 weeks of 
gestation were stained. Scale bar 50 µm. (Arrowheads: SSEA1+/NANOG- cells). 
Supplementary Figure 3. Chromatin changes of H3K4me1 in human fetal PGCs.  
A Immunofluorescence of primordial germ cells and somatic cells for detecting 
H3K4me1 (green), VASA (red), OCT4 (yellow) and DAPI (blue) proteins. Fetal ovaries 
and testis were stained. Scale bar 10 µm.  
B Quantification of H3K4me1 signal in human germ and somatic cells. The error bars 
represent standard deviation. 
Supplementary Figure 4. Chromatin changes of H3K9me3 in human fetal PGCs.  
A Immunofluorescence of primordial germ cells and somatic cells for detecting 
H3K9me3 (green), VASA (red), OCT4 (yellow) and DAPI (blue) proteins. Fetal ovaries 
and testis were stained. Scale bar 10 µm.  
B Quantification of H3K9me3 signal in human germ and somatic cells. The error bars 
represent standard deviation. 
Supplementary Figure 5. The expression of Prmt5 in human fetal gonads. 
Immunofluorescence of primordial germ cells and somatic cells for detecting PRMT5 
(green), VASA (red), OCT4 (yellow) and DAPI (blue) proteins. Scale bar 10 µm. (*: 
Heterogeneity in VASA staining). 
A Fetal testis from 7 to 13 weeks of gestation 
B Fetal ovaries from 7 to 13 weeks of gestation   
C Quantification of nuclear and cytoplasmic PRMT5 staining in fetal testis and ovaries.  
Supplementary Figure 6. The expression of DHX38 in human fetal gonads. 
Immunofluorescence of primordial germ cells and somatic cells for detecting DHX38 
(green), VASA (red), OCT4 (yellow) and DAPI (blue) proteins. Scale bar 10 µm. 
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A Fetal ovaries from 6 to 13 weeks of gestation  
B Fetal testis from 6 to 13 weeks of gestation.  
Supplementary Figure 7. Quantification of the overall histone marks in human 
germ cells. The error bars represent standard deviation. Somatic cells normalized to 1.0. 
